NASDAQ: TPTX - Turning Point Therapeutics, Inc.

Lønnsomhet i seks måneder: 0%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Turning Point Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Turning Point Therapeutics, Inc.

Turning Point Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается проектированием и разработкой новых низкомолекулярных таргетных онкологических препаратов. Он разрабатывает набор ингибиторов тирозинкиназы (TKI), который нацелен на генетические факторы рака у пациентов, ранее не получавших TKI, и пациентов, получавших лечение TKI.

flere detaljer
Ведущий кандидат в лекарственный препарат репотректиниб оценивается в продолжающемся исследовании III фазы под названием TRIDENT-1 для лечения пациентов с распространенным немелкоклеточным раком легкого (НМРЛ) ROS1 + и пациентов с распространенными солидными опухолями ROS1 +, NTRK + или ALK +. Его портфель также включает в себя многоцелевые лекарственные препараты-кандидаты TPX-0046, ингибитор RETSRC; TPX-0022, ингибитор METCSF1RSRC; и TPX-0131, доклинический ингибитор ALK. Компания была основана в 2013 году, ее штаб-квартира находится в Сан-Диего, Калифорния.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2006-10-04
ISIN US90041T1088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.tptherapeutics.com
Цена ао 75.18
Prisendring per dag: 0% (76.01)
Prisendring per uke: 0% (76.01)
Prisendring per måned: 0% (76.01)
Prisendring over 3 måneder: 0% (76.01)
Prisendring over seks måneder: 0% (76.01)
Prisendring per år: 0% (76.01)
Prisendring over 3 år: +198.31% (25.48)
Prisendring over 5 år: +84.76% (41.14)
Prisendring siden begynnelsen av året: 0% (76.01)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 609.13 1
P/BV 4.16 4
P/E 0 0
EV/EBITDA 0.8457 10
Total: 4.13

Effektivitet

Navn Betydning Karakter
ROA, % -37.07 0
ROE, % -39.18 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0145 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -89.85 0
Lønnsomhet Ebitda, % 1222.75 10
Lønnsomhet EPS, % 315.06 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Fidelity Management & Research Company LLC 3492634 7.25
Cormorant Asset Management, LLC 3037042 6.15
Orbimed Advisors, LLC 2361327 4.78
Fidelity SelectCo, LLC 2012858 4.07
Fidelity Management & Research Company LLC 1974333 4
American Century Investment Management, Inc 934996 1.89
Northern Trust Investments Inc 917027 1.86
Wells Fargo Funds Management LLC 792139 1.6
PGIM Investments LLC 644625 1.3
Fidelity Institutional Asset Management 517107 1.05
Allspring Funds Management LLC 508120 1.03
Candriam Belgium 503875 1.03
Consonance Capital Management LP 450396 0.92
Harbor Capital Advisors Inc 444261 0.9
Hartford Funds Management Company, LLC 405235 0.82
Logos Global Management LP 400000 0.81
First Light Asset Management, LLC 395825 0.8
MPM Oncology Impact Management LP 269186 0.54
Sectoral Asset Management Inc 257379 0.52
BNP Paribas Asset Management Luxembourg 244617 0.5
Nationwide Fund Advisors 137077 0.28
International Biotechnology Trust PLC 121541 0.25
SV Life Sciences Managers LLP 121541 0.25
Federated MDTA LLC 112514 0.23
Parkman Healthcare Partners LLC 110335 0.23
New York Life Investment Management LLC 109243 0.22
Osterweis Capital Management LLC 104585 0.21
The Variable Annuity Life Insurance Company 96043 0.19
MML Investment Advisers, LLC 89844 0.18
Prudential Retirement Services 86566 0.18
Arctic Asset Management AS 77723 0.16
Burrage Capital Management LLC 72164 0.15
Osterweis Capital Management 67400 0.14
Fidelity Investments Canada ULC 49821 0.1
Driehaus Capital Management (USVI) LLC 34985 0.07
AMG Funds LLC 27891 0.06
Nicholas Investment Partners 12856 0.03
Munder Lee Investments Ltd 8117 0.02
First Trust Portfolios L.P. 7079 0.01
Peroni Portfolio Advisors, Inc 400 0

ETFDele, %Lønnsomhet for året, %Utbytte, %
ProShares UltraShort Nasdaq Biotechnology 0.26 -40.36 1.76
0.26-40.361.76



Veileder Stillingstittel Betaling Fødselsår
Mr. Ed Gemo Sr. VP & Chief Information Officer N/A
Ms. Heather Adams Sr. VP of HR N/A
Dr. Athena Maria Countouriotis M.D. Pres, CEO & Director 1.19M 1972 (53 år)
Mr. Paolo Tombesi Exec. VP & CFO 741.19k 1964 (61 år)
Dr. Adam D. Levy M.B.A., Ph.D. Sr. VP of Investor Relations & Corp. Communications N/A
Mr. Raymond J. Furey J.D. Sr. VP & Chief Compliance Officer N/A 1968 (57 år)
Dr. Mohammad Hirmand Exec. VP & Chief Medical Officer 783.77k 1970 (55 år)
Dr. Gavin Hirst Ph.D. Sr. VP of Chemistry & Interim Chief Scientific Officer N/A
Mr. Brian Sun J.D., M.S. Sr. VP, Gen. Counsel & Corp. Sec. N/A 1984 (41 år)
Dr. Jeffrey P. Whitten Sr. VP of Pre-Clinical Devel.

Adresse: United States, San Diego, CA , 10628 Science Center Drive - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.tptherapeutics.com